Molekulare Tumorpathologie
Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells..
Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells..
Oncogenic signaling pathways and deregulated target genes..
Suppression of the TIG3 tumor suppressor gene in human ovarian carcinomas is mediated via mitogen-activated kinase-dependent and -independent mechanisms..
Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation..
HMGA2 gene is a promising target for ovarian cancer silencing therapy..
A systems biological approach suggests that transcriptional feedback regulation by dual-specificity phosphatase 6 shapes extracellular signal-related kinase activity in RAS-transformed fibroblasts..
The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells..
Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells.
A genome-wide survey of RAS transformation targets..